These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29127442)

  • 1. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.
    Carvalheiro T; Horta S; van Roon JAG; Santiago M; Salvador MJ; Trindade H; Radstake TRDJ; da Silva JAP; Paiva A
    Inflamm Res; 2018 Feb; 67(2):169-177. PubMed ID: 29127442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.
    Fineschi S; Goffin L; Rezzonico R; Cozzi F; Dayer JM; Meroni PL; Chizzolini C
    Arthritis Rheum; 2008 Dec; 58(12):3913-23. PubMed ID: 19035500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells.
    Monnier J; Quillien V; Piquet-Pellorce C; Leberre C; Preisser L; Gascan H; Samson M
    Eur Cytokine Netw; 2008 Dec; 19(4):166-75. PubMed ID: 19103522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
    Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
    Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
    Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
    Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
    Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
    Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.
    Horikawa M; Hasegawa M; Komura K; Hayakawa I; Yanaba K; Matsushita T; Takehara K; Sato S
    J Invest Dermatol; 2005 Oct; 125(4):731-7. PubMed ID: 16185273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.
    Piccioli D; Tavarini S; Borgogni E; Steri V; Nuti S; Sammicheli C; Bardelli M; Montagna D; Locatelli F; Wack A
    Blood; 2007 Jun; 109(12):5371-9. PubMed ID: 17332250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.
    van Bon L; Cossu M; Loof A; Gohar F; Wittkowski H; Vonk M; Roth J; van den Berg W; van Heerde W; Broen JC; Radstake TR
    Ann Rheum Dis; 2014 Aug; 73(8):1585-9. PubMed ID: 24718960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.
    Choreño-Parra JA; Cervantes-Rosete D; Jiménez-Álvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Magaña-Sánchez AY; Lima G; López-Maldonado H; Gaytán-Guzmán E; Caballero A; Fernández-Plata R; Furuzawa-Carballeda J; Mendoza-Milla C; Navarro-González MDC; Llorente L; Zúñiga J; Rodríguez-Reyna TS
    Rheumatology (Oxford); 2023 Apr; 62(4):1687-1698. PubMed ID: 36063053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis.
    Villanueva-Martin G; Acosta-Herrera M; Carmona EG; Kerick M; Ortego-Centeno N; Callejas-Rubio JL; Mages N; Klages S; Börno S; Timmermann B; Bossini-Castillo L; Martin J
    J Autoimmun; 2023 Nov; 140():103097. PubMed ID: 37633117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
    van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
    Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
    Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
    Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
    Hasegawa M; Sato S; Takehara K
    Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
    Guo M; Guo H; Zhu J; Wang F; Chen J; Wan C; Deng Y; Wang F; Xu L; Chen Y; Li R; Liu S; Zhang L; Wang Y; Zhou J; Li S
    Diabetologia; 2024 Apr; 67(4):623-640. PubMed ID: 38349399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
    Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
    Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.